:: OIPA Home :: UCLA Home :: Collaboration Newsletter ::  
Contact
 

http://www.research.ucla.edu/tech/therapeutics.htm
  • 2008-490 Selective Kinase Inhibitor Decreases Atherosclerosis
  • 2008-488 Novel Peptides Promote Neurosurvival and Insulin Sensitization
  • 2008-488 Novel Peptide Induces Apoptosis and Inhibits Cell growth and Angiogenesis
  • 2008-483 Parathyroid Hormone (PTH) Supplement for Osteoporosis
  • 2008-234 Strategy to Suppress Dominant Oncogene in Leukemia Using Lentiviral Expressed microRNAs
  • 2008-217 A Novel Method for the Inhibition fo HIV Assembly and Budding
  • 2008-213 QEEG Method to Predict Treatment Response in Fibromyalgia
  • 2008-211 Peptide for Induction of Immune Tolerance as Treatment for Systemic Lupus Erythematosus (SLE)
  • 2008-210 Hypocretin (HCRT-1) Administration to Treat Narcolepsy and Obesity
  • 2008-128 Aptamer-mediated Correction of Lysosomal Enzyme Deficiency
  • 2008-027 Regeneration of the Intestinal Wall
  • 2007-791 Estrogen Receptor Ligand Treatment for Neurodegenerative Diseases
  • 2007-574 Ordered Vertically Oriented Porous Inorganic Films Produced Through Solution Processing
  • 2007-480 Novel Therapeutic Target for Treating Behavioral and Learning Disabilities
  • 2007-452 Intervention with Atherosclerosis and Related Complications by Novel Targeting of Hedgehog
  • 2007-383 Receptor Target for Treating Human Diseases Through the Mediation of Cellular Vitamin A and Reinoid Uptake
  • 2007-310 Improved Drug Delivery to Cancer Cells Using Modified Transferrin
  • 2007-251 Synthetic Peptide for the Vaccination of Systemic Lupus Erythematosus
  • 2007-250 Antibody Mediated Gene Delivery of the Tumor Suppressor Protein p53
  • 2007-223 Novel Vaccines Against Tularemia
  • 2007-217 Novel Tumor Associated Antigen Variant for Renal Cell Carinoma Diagnosis and Therapy
  • 2007-216 Vectors for Antibody Expression
  • 2007-189 Click Chemistry Inhibitors of Protein Kinase B/Akt
  • 2007-145 Small Protein-mediated Therapy for the Treatment of Muscular Dystrophy
  • 2007-106 Natural Release of Peptides that Inhibit food Intake
  • 2007-095 Self-contained Cell Culture Device for Cell Separation and Sorting
  • 2007-094 Medication Treatment for Reducing Psychostimulant Drug Cravings
  • 2007-053 A Novel Serum Marker to Assess Oncogenic Signaling of Human Cancers
  • 2007-014 Polypeptide Vesicles for Intracellular Drug Delivery
  • 2006-739 Strategy for Inhibiting the Hedgehog Pathway in Pathological Settings
  • 2006-584 Drug for Dialysis-related Amyloidosis
  • 2006-539 New Recombinant Tuberculosis BCG Vaccine for Immunocompromised Patients and Others
  • 2006-538 Recombinant Tuberculosis BCG Vaccine Elicits a Highly Protective Host Immune Response
  • 2006-522 Fusion Protein for Delivering IFN-α in Treating B-Cell Lymphoma
  • 2006-389 Uses of Urolithins in Treatment of Cancer
  • 2006-357 Novel Non-peptidomimetic Prenyl Transferase Inhibitors
  • 2006-264 Nano Particles with Natural Anti-microbial Properties
  • 2006-095 Method for Prevention and Alleviation of Acetaminophen-Induced Hepatotoxicity
  • 2006-064 Improved Plasmin Inhibitor to Stop Bleeding
  • 2005-743 Maleimide Tumor Antigen-carrier Protein Conjugates for Cancer
  • 2005-741 Novel Treatment for Post-operative Gastric Ileus
  • 2005-604 Soluble and Cell-Associated Hemojuvelins as a Therapy and Diagnostic for Iron Metabolism Diseases
  • 2005-555 Prevention and Treatment of Chlamydia trachomatis Infection Using a Protective Antibody
  • 2005-497 Potential Treatment for Reducing Myocardial Infarct Size
  • 2005-478 Potential Biomarker and Therapeutic Target for Endometrial Carcinoma
  • 2005-458 Alcohol Receptors with Methods to Develop Compounds for the Treatment of Alcoholism and Anxiety
  • 2005-379 Improvement of Dental Resins: Decreased toxicity and improved biocompatibility
  • 2005-351 Broad-spectrum Anti-microbial Peptide for the Treatment of Acne and Skin Cancer
  • 2005-098 Antibody Therapy for Inhibiting Bladder Cancer and Prostate Cancer Metastasis
  • 2005-056 Single Nucleotide Polymorphism for Corticotropin-releasing Hormone 1 Receptor (CRHR1), A Biomarker for Predicting Drug Response to Fluoxetine and Despiramine Therapy
  • 2005-017 Novel Prognostic Factor and Therapeutic Target in Human Renal Cell Carcinoma


  • 2004-675 An Intelligent Nanomedicine Integrating Diagnosis and Therapy
  • 2004-670 Potential Therapeutic for Catamenial Epilepsy and Pre-menstrual Dysphoric Disorder
  • 2004-598 Breakthrough Treatment for the Learning and Memory Deficiencies Associated with Neurofibromatosis Type 1
  • 2004-435 Efficiency of Anti-PSMA Antibodies
  • 2004-275 A MXXXL Motif Confering Endocytosis of Biomolecules
  • 2004-096 Identification of the First Human Glucose Sensor—A New Target for Treatment of Diabetes, Obesity, and Related Metabolic Disorders


  • 2003-450 Phospho-Specific Antibody for CaM Kinase II
  • 2003-314 Method to Assemble an Eukaryotic Capsule-like Organelle In-situ and using it to Encapsulate Biomolecules (Proteins, Peptides, Biosensors), to Sequester Toxins and Contaminants, and in Other Nano-Electrical Machine (NEMS) Applications
  • 2003-189 Liver X Receptor (LXR) Ligands as Treatments for Type II Diabetes, Obesity and Related Disorders
  • 2003-188 Liver X Receptor (LXR) Agonists as Anti-Inflammatory Agents in Macrophage-Dependent Inflammatory Diseases
  • 2003-051 Vaccination Against Tumor-Associated Herpesviruses

  • 2002-483 Novel Signaling Molecule Utilized By S. Mutans for Bio-film Formation and Quorum Sensing
  • 2002-479 New Treatment Strategy for Gamma-Herpes Virus Associated Malignancies Using Inhibitors of the NF-KB Pathway
  • 2002-463 Method for Using Carbonic Anhydrase IX as a Molecular Marker for Predicting Survival in Advanced Renal Clear Cell Carcinoma
  • 2002-428 Polyphenolic Compounds Inhibit Pancreatic Cancer
  • 2002-427 Curcumin as a Treatment for Pancreatitis
  • 2002-422 A Method to Induce Anti-Viral Responses
  • 2002-185 Prophylactic and Chemotherapeutic Method for Treating Tuberculosis
  • 2002-004 Vector for Tissue Specific Amplification of Both Reporter and Therapeutic Genes


    •
  • 2001-425 Receptor Interacting Protein 2 (rip2) in Development of Immune Response
  • 2001-381 Use of Secondary Lymphoid Organ Chemokine to Induce Anti-tumor Response by Stimulating Cell-mediated Immune Response and Inhibiting Angiogenesis
  • 2001-329 Retrocyclin: an Anti-Retroviral Circular Minidefensin
  • 2001-194 Wit 3.0, a Novel Gene to Control Soft Tissue Wound Healing
  • 2000-479 GDOX, A Novel Candidate Proto-oncogene


    •
  • 2000-377 Live Recombinant Tuberculosis Vaccine
  • 2000-236 Granulin as a Target for Tumor Diagnosis and Growth Regulation
  • 2000-203 Anti-Sense Oligonucleotide Targeted Prophylactic and Chemotherapeutic Agent Against Mycobacterium Tuberculosis
  • 2000-128 Targeting Lentiviral Vectors to Specific Cells and Tissues
  • 2000-044 Universal Vectors for Drug Delivery


  • 1999-560 NELL-1 Protein With Activity In Bone Formation
  • 1999-556 HIV Protein Moderates Telomerase

  • 1998-610 Hybrid IgA/IgG Polymeric Antibodies
  • 1998-556 GM-CSF and IL-4 Therapy for the In-Situ Expansion of Dendritic Cells and Enhancement of Vaccine-based Immunity
  • 1998-541 Specific Inhibitors of Cytokine Signaling

  • 1997-543 Reaction of Purines with Elemental Fluorine to Generate 8-Fluoropurines
  • 1997-538 Methods for Modulating the Activation of a G-protein Couple Receptor (g2a) Involved in Cell Proliferation, Autoimmunity and Inflammation
  • 1997-517 Use of a B Cell Superantigen Peptide as an Immunogen
  • 1997-505 A Protein of Mycobacterium Tuberculosis Stimulates Interleukin-12 Production

  • 1996-615 Mutations in Ataxia-Telangiectasia Gene
  • 1996-604 Targeted Prophylactic and Chemotherapeutic Agents Againstmycobacterium Tuberculosis
  • 1996-592 Cerberus and FRZB-1, Secretory Molecules with a Regenerative Function and an Inhibitory Activity on WNTS, Respectively
  • 1996-528 Method and Device for Treating Intracranial Vascular Aneurysms
  • 1996-525 Treatment of Polycystic Kidney Disease: Pharmacological Compounds and in Vitro Screening System
  • 1996-507 Dax-1 Promoter: DNA Sequence Driving Adrenal Cortical Cell-specific Expression

  • 1995-597 Anti-Vault Therapy for Multi-drug Resistance to Chemotherapy
  • 1995-593 Neuro-Endovascular Ultrasound Thrombolysis
  • 1995-579 Anti-Microbial Targeting for Intracellular Pathogens

  • 1994-541 Chordin, a Secreted BMP Antagonist
  • 1994-518 Prophenins: Proline-Rich Antimicrobial Peptides with Repetitive Decamersequence

  • 1993-564 Novel Gene Therapy for AIDS Using Mutated tRNAs
  • 1993-501 Organic Compounds for the Treatment of Myocardial Infarction

  • 1992-510 Immunoglobulin Superantigen Binding to GP120 from HIV

  • 1991-573 Cloned Vesicular Amine Transporters and Methods for Drug Screening and Gene Therapy
  • 1991-561 Restoration of Impaired Cellular Immune Function
  • 1991-543 Natural Killer Enhancing Factor
  • 1991-515 Method and Composition for Treatment of Kaposi's Sarcoma

    		• UCLA
    Technologies
    Available for Licensing

    please select from below:
    All Life Sci Tech
    All Phy Sci Tech

    :: OIP Home Page

    The Office of Intellectual Property (OIP) manages a campus-wide patent and invention portfolio resulting from UCLA research funded by more than $750 million per year in federal, state and private contracts and grants.

     Contact information:

     Office of Intellectual Property
    11000 Kinross Ave., Suite 200
    Los Angeles, CA 90095-1406
    Tel. 310.794.0558

    http://www.research.ucla.edu/oip



    :: UCLA Lab Directory


    :: UCLA Research Interests
    :: Collaboration Newsletter


    :: Campus Directory
    :: UCLA main research page
    :: UCLA Home Page
    :: About UCLA


    Copyright © 2003 The Regents of the University of California